HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brent Johnston Selected Research

CRX-526

9/2015Experimental TLR4 inhibition improves intestinal microcirculation in endotoxemic rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brent Johnston Research Topics

Disease

16Neoplasms (Cancer)
01/2022 - 04/2009
11Neoplasm Metastasis (Metastasis)
01/2022 - 04/2009
6Breast Neoplasms (Breast Cancer)
01/2021 - 01/2015
5Infections
01/2021 - 09/2010
5Inflammation (Inflammations)
09/2019 - 04/2002
4Carcinoma (Carcinomatosis)
01/2020 - 03/2015
3Vesicular Stomatitis
01/2022 - 09/2017
3Melanoma (Melanoma, Malignant)
01/2015 - 04/2009
2Fibrosis (Cirrhosis)
02/2017 - 08/2015
2Sepsis (Septicemia)
09/2015 - 12/2012
2Endotoxemia
09/2015 - 12/2012
2Experimental Arthritis
11/2014 - 06/2014
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1Adenocarcinoma
01/2022
1Ovarian Neoplasms (Ovarian Cancer)
01/2021
1Peritoneal Neoplasms
01/2021
1Uveitis
09/2019
1Parasitic Diseases (Parasitic Disease)
01/2019
1Visceral Leishmaniasis (Kala Azar)
01/2019
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2018
1Proliferative Vitreoretinopathy
02/2017
1Experimental Melanoma
01/2016
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
11/2014
1Arthritis (Polyarthritis)
11/2014
1Rheumatoid Arthritis
11/2014
1Psoriatic Arthritis
11/2014
1Hypersensitivity (Allergy)
06/2014
1Peritonitis
12/2012
1Virus Diseases (Viral Diseases)
09/2010
1Ascites
08/2006

Drug/Important Bio-Agent (IBA)

7CytokinesIBA
01/2022 - 11/2009
7GlycolipidsIBA
10/2021 - 11/2009
4AntigensIBA
01/2021 - 06/2014
4ChemokinesIBA
01/2021 - 04/2002
3Chemokine ReceptorsIBA
11/2014 - 07/2002
2AntibodiesIBA
01/2022 - 11/2014
2LipidsIBA
10/2021 - 01/2015
2CannabinoidsIBA
09/2019 - 02/2017
2TicagrelorIBA
01/2018 - 01/2015
2Adenosine Triphosphate (ATP)IBA
12/2017 - 12/2015
2HMGB1 Protein (HMG1)IBA
12/2017 - 12/2015
2InterferonsIBA
09/2017 - 01/2016
1Interleukin-15 (Interleukin 15)IBA
01/2022
1Galactosylceramides (Galactocerebrosides)IBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020
1InterleukinsIBA
01/2020
1Interleukin-17 (Interleukin 17)IBA
01/2020
1Pharmaceutical PreparationsIBA
09/2019
1LigandsIBA
09/2019
1EndotoxinsIBA
09/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019
1Conditioned Culture MediaIBA
01/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019
1Dihydrotachysterol (AT 10)IBA
01/2018
1Clopidogrel (Plavix)FDA Link
01/2018
1CalreticulinIBA
12/2017
1Histocompatibility Antigens Class IIBA
12/2017
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2017
1GemcitabineFDA Link
12/2017
1Proteins (Proteins, Gene)FDA Link
09/2017
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2016
1Toll-Like Receptor 3IBA
12/2015
1AnthracyclinesIBA
12/2015
1CRX-526IBA
09/2015
1Acetylcysteine (Siran)FDA LinkGeneric
08/2015
1Adenosine Diphosphate (ADP)IBA
01/2015
1Purinergic P2Y12 ReceptorsIBA
01/2015
1Immunoglobulin G (IgG)IBA
11/2014
1CollagenIBA
11/2014
1Concanavalin AIBA
06/2014
1Poly I-CIBA
06/2014
1LipopolysaccharidesIBA
12/2012
1HU 308IBA
12/2012
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
12/2012
1salicylhydroxamic acid (SHAM)IBA
12/2012
1iodopravadoline (AM 630)IBA
12/2012
1matrigelIBA
12/2010
1Toll-Like Receptor AgonistsIBA
12/2010
1Interleukin-6 (Interleukin 6)IBA
12/2010
1Transcription Factors (Transcription Factor)IBA
09/2010
1Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA
09/2010
1alpha-galactosylceramideIBA
11/2009
1C-galactosylceramideIBA
11/2009
1Endothelial Protein C ReceptorIBA
04/2009
1drotrecogin alfa activated (Xigris)FDA Link
04/2009
1Protein CIBA
04/2009
1CalciumIBA
08/2006

Therapy/Procedure

7Immunotherapy
01/2022 - 12/2010
3Therapeutics
01/2022 - 12/2017
3Drug Therapy (Chemotherapy)
01/2022 - 12/2015
1Oncolytic Virotherapy
01/2022
1Intravenous Administration
01/2021
1Mammaplasty (Breast Reconstruction)
01/2019
1Stents
12/2012